Screening for syphilis with the treponemal immunoassay: Analysis of discordant serology results and implications for clinical management

Journal of Infectious Diseases

Volumn 204, Issue 9, 2011, Pages 1297-1304

  Park, Ina U ^a,b   Chow, Joan M ^a   Bolan, Gail ^a   Stanley, Mark ^c   Shieh, Jennifer ^c   Schapiro, Jeffrey M ^d  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AFRICAN AMERICAN; AGGLUTINATION TEST; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; GENITAL ULCER; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NEUROLOGIC DISEASE; PREGNANT WOMAN; PRIORITY JOURNAL; RACE DIFFERENCE; RASH; SCREENING TEST; SEROCONVERSION; SYPHILIS; SYPHILIS SEROLOGY; TREPONEMA PALLIDUM;

ADULT; CALIFORNIA; FEMALE; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; SEXUAL BEHAVIOR; SYPHILIS; TREPONEMA PALLIDUM;

EID: 80053388174     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir524     Document Type: Article

References (30)

1. Mehta SD, Ghanem KG, Rompalo AM. Erbelding EJ. HIV seroconversion among public sexually transmitted disease clinic patients: analysis of risks to facilitate early identification. J Acquir Immune Defic Syndr 2006; 42:116-22. (Pubitemid 43947956)
2. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL. Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-33.
3. Greenblatt RM, Lukehart SA, Plummer FA, et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988; 2:47-50. (Pubitemid 18085319)
4. Fenton KA, Breban R, Vardavas R, et al. Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis 2008; 8:244-53. (Pubitemid 351391990)
5. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2008. Atlanta, GA: US Department of Health and Human Services, 2009.
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:35-49.
7. Pope V. Use of treponemal tests to screen for syphilis. Infect Med 2004; 21:399-404.
8. French P, Gomberg M, Janier M, Schmidt B, van Voorst Vader P, Young H. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS 2009; 20:300-9.
9. Philips-Rodriguez D, Perlman D, Schillinger J. Past and current syphilis diagnoses among Treponema pallidum EIA1/RPR-patients with a high rate of HIV infection; findings from medical record review, New York City 2008-2009. Atlanta, GA: Centers for Disease Control and Prevention National STD Prevention Conference, 2010.
10. Peterman T, Schillinger J, Blank S, et al. Syphilis testing algorithms using treponemal tests for initial screening-four laboratories, New York City, 2005-2006.MMWRMorb Mortal Wkly Rep 2008; 57:872-5.
11. Pohl D, Hotton A, Gratzer B, et al. Discordant syphilis EIA test results: are newer tests Better? Atlanta, GA: Centers for Disease Control and Prevention National STD Prevention Conference, 2010.
12. California Department of Public Health-Sexually Transmitted Disease Control Branch. Sexually transmitted diseases testing in California-2007 clinical laboratory survey summary. Richmond, CA: California Department of Public Health, 2009.
13. Woznicova V, Valisova Z. Performance of CAPTIA SelectSyph-G enzymelinked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results. J Clin Microbiol 2007; 45:1794-7. (Pubitemid 46933909)
14. Halling VW, Jones MF, Bestrom JE, et al. Clinical comparison of the Treponema pallidum CAPTIA syphilis-G enzyme immunoassay with the fluorescent treponemal antibody absorption immunoglobulin G assay for syphilis testing. J Clin Microbiol 1999; 37:3233-4. (Pubitemid 29455211)
15. Marangoni A, Sambri V, Accardo S, et al. Evaluation of LIAISON Treponema Screen, a novel recombinant antigen-based chemiluminescence immunoassay for laboratory diagnosis of syphilis. Clin Diagn Lab Immunol 2005; 12:1231-4. (Pubitemid 41475833)
16. Knight CS, Crum MA. Hardy RW. Evaluation of the LIAISON chemiluminescence immunoassay for diagnosis of syphilis. Clin Vaccine Immunol 2007; 14:710-3. (Pubitemid 47104757)
17. Chuck A, Ohinmaa A, Tilley P, Singh A. Jacobs P. Cost effectiveness of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis. Int J STD AIDS 2008; 19:393-9.
18. Kaiser Permanente. Fast facts about Kaiser Permanente. http://xnet.kp.org/newscenter/aboutkp/fastfacts.html. Accessed 21 May 2010.
19. Centers for Disease Control and Prevention. Discordant results from reverse sequence syphilis screening-five laboratories, United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2011; 60:133-7.
20. Mishra S, Boily MC, Ng V, et al. The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the greater Toronto area. Sex Transm Dis 2010; 38:190-6.
21. Borenstein LA, Spotkov JM, Cox DA. Novak-Weekley SM. High throughput laboratory experience using the TREP-CHEK-EIA as a screening test for syphilis. Orlando, FL: American Society for Microbiology, 2006.
22. Owusu-Edusei K Jr, Peterman TA. Ballard RC. Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms. Sex Transm Dis 2011; 38:1-7.
23. Creegan L, Bauer HM, Samuel MC, Klausner J, Liska S. Bolan G. An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis. Sex Transm Dis 2007; 34:1016-8. (Pubitemid 350158855)
24. Centers for Disease Control and Prevention. Sexually Transmitted Diseases treatment guildelines 2010. MMWR Morb Mortal Wkly Rep 2010; 59:1-110.
25. Marra CM, Maxwell CL, Tantalo LC, Sahi SK. Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47:893-9.
26. Wohrl S, Geusau A. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL-test. Acta Derm Venereol 2006; 86:335-9. (Pubitemid 44133381)
27. Libois A, De Wit S, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34:141-4. (Pubitemid 46673215)
28. Macy E, Poon K-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 2009; 122:778 e1-7.
29. Wong EH, Klausner JD, Caguin-Grygiel G, et al. Evaluation of an IgM/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population. Sex Transm Dis 2011; 38:528-32.
30. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82:703-10.